Basit öğe kaydını göster

dc.contributor.authorApak, Resat
dc.contributor.authorOzyurek, Mustafa
dc.contributor.authorAkpinar, Damla
dc.contributor.authorGuclu, Kubilay
dc.contributor.authorBener, Mustafa
dc.contributor.authorTurkkan, Baki
dc.date.accessioned2021-03-04T10:31:27Z
dc.date.available2021-03-04T10:31:27Z
dc.identifier.citationOzyurek M., Akpinar D., Bener M., Turkkan B., Guclu K., Apak R., "Novel oxime based flavanone, naringin-oxime: Synthesis, characterization and screening for antioxidant activity", CHEMICO-BIOLOGICAL INTERACTIONS, cilt.212, ss.40-46, 2014
dc.identifier.issn0009-2797
dc.identifier.othervv_1032021
dc.identifier.otherav_6d9ad710-ab22-4b6f-ba20-14ad988e4e39
dc.identifier.urihttp://hdl.handle.net/20.500.12627/75714
dc.identifier.urihttps://doi.org/10.1016/j.cbi.2014.01.017
dc.description.abstractRecent interest in polyphenolic antioxidants due to their involvement in health benefits has led to the investigation of new polyphenolic compounds with enhanced antioxidant activity. Naringin (4 ',5,7-tri-hydroxyflavanone-7-beta-L-rhamnoglucoside-(1,2)-alpha-D-glucopyranoside) is one of the major flavanones in citrus and grapefruit. The present study aimed to synthesize naringin oxime from naringin and to evaluate its antioxidant and anticancer potential using in vitro assay system. The structure of the synthesized compound, naringin oxime, was elucidated by FT-IR, H-1 NMR, elemental analysis and UV-vis spectroscopy. Antioxidant capacity of naringin oxime, as measured by the cupric reducing antioxidant capacity (CUPRAC) method, was found to be higher than that of the parent compound naringin. Other parameters of antioxidant activity (scavenging effects on OH center dot, O-2(center dot-), and H2O2) of naringin and naringin oxime were also determined. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
dc.language.isoeng
dc.subjectPharmacology (medical)
dc.subjectPharmacy
dc.subjectDrug Guides
dc.subjectPhysical Sciences
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectDrug Discovery
dc.subjectAging
dc.subjectGeneral Biochemistry, Genetics and Molecular Biology
dc.subjectGeneral Pharmacology, Toxicology and Pharmaceutics
dc.subjectPharmacology, Toxicology and Pharmaceutics (miscellaneous)
dc.subjectBiochemistry
dc.subjectStructural Biology
dc.subjectHealth, Toxicology and Mutagenesis
dc.subjectBİYOKİMYA VE MOLEKÜLER BİYOLOJİ
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectTOKSİKOLOJİ
dc.subjectSağlık Bilimleri
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectMeslek Bilimleri
dc.subjectFarmasötik Toksikoloji
dc.subjectYaşam Bilimleri
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectSitogenetik
dc.subjectTemel Bilimler
dc.subjectBiochemistry, Genetics and Molecular Biology (miscellaneous)
dc.subjectToxicology
dc.subjectClinical Biochemistry
dc.subjectCancer Research
dc.subjectPharmacology
dc.subjectMolecular Biology
dc.titleNovel oxime based flavanone, naringin-oxime: Synthesis, characterization and screening for antioxidant activity
dc.typeMakale
dc.relation.journalCHEMICO-BIOLOGICAL INTERACTIONS
dc.contributor.departmentHarran Üniversitesi , ,
dc.identifier.volume212
dc.identifier.startpage40
dc.identifier.endpage46
dc.contributor.firstauthorID11347


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster